张煜医生发致歉声明:将退出直播

2021-06-16 梅斯医学 梅斯医学

6月10日晚,他在其个人微博上,发了一条“致歉声明”。

张煜医生肿瘤“揭黑”事件,以陆巍医生被罚3万元和停职6个月,以及上海新华医院被处警告并罚款4万元;上海嘉慷生物工程有限公司因“擅自执业”,被罚没总计165万元而偃旗息鼓。

先前报道:张煜再发文质疑卫健委专家团 希望全国公开辩论“肿瘤治疗事件”;

“肿瘤治疗黑幕”当事医生陆巍首次正面回应各种指控,国家卫健委回应调查结果

6月10日晚,他在其个人微博上,发了一条“致歉声明”。张煜医生称,因其家人担心他的人身安全和工作,以及带来麻烦,他不得不暂停知乎上的直播,所以道歉。

 

图片

 

全文如下:

致歉声明

我从来不想当食言而肥的人,但这次不得不如此,所以只能道歉。

昨天我还很开心,因为我知道做直播是正确的事,我也想这么做,我已经说服了我的爱人同意,并且有知乎的工作人员帮助,一切都似乎很顺利。

直到今天早上接到了我的家人的电话,出于担心我的人身安全、担心我的工作、以及可能陷入麻烦等原因,一定要求我停止直播,并且不能商谈。我只能苦笑和同意,是我对不起各位,尤其是知乎的工作人员,他们之前的一些工作相当于浪费了。很遗憾,直播估计没有机会出现了。

其实我觉得家人的观念可能都不对,请想想,就算我愿意息事宁人、永远退出知乎和微博,一些因为我利益受损的人就会放过我?我真不觉得,大概率是当我失去关注的时候,就是更大的风险来临的时候。

所以,这也是魔幻,现在为什么做些正确的、能够帮助别人的事情,却会碰见这么多阻力甚至直接面临风险?当然,我也不曾后悔,无论面对什么,也会坦然。

我其实现在挺难过的,但也只能接受现实。既然不能直播,以后只要有精力,我会多写一些科普知识。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=974858, encodeId=168e9e485836, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6e65529012, createdName=ms3000002003870090, createdTime=Sat Jun 19 12:50:03 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974424, encodeId=a71a9e442439, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Thu Jun 17 16:33:15 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974161, encodeId=17a09e41618c, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:42 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974160, encodeId=30fc9e41604f, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:13 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974147, encodeId=37009e414751, content=好医生, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/2d59f54660e6480cacdbb2833517659d/12b1bb8ee93a41c59a96fcf76a4155c4.jpg, createdBy=b3e85427384, createdName=ms1000001373606354, createdTime=Wed Jun 16 17:56:14 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-19 ms3000002003870090

    不错学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=974858, encodeId=168e9e485836, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6e65529012, createdName=ms3000002003870090, createdTime=Sat Jun 19 12:50:03 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974424, encodeId=a71a9e442439, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Thu Jun 17 16:33:15 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974161, encodeId=17a09e41618c, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:42 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974160, encodeId=30fc9e41604f, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:13 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974147, encodeId=37009e414751, content=好医生, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/2d59f54660e6480cacdbb2833517659d/12b1bb8ee93a41c59a96fcf76a4155c4.jpg, createdBy=b3e85427384, createdName=ms1000001373606354, createdTime=Wed Jun 16 17:56:14 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-17 仁术2021

    不错学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=974858, encodeId=168e9e485836, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6e65529012, createdName=ms3000002003870090, createdTime=Sat Jun 19 12:50:03 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974424, encodeId=a71a9e442439, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Thu Jun 17 16:33:15 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974161, encodeId=17a09e41618c, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:42 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974160, encodeId=30fc9e41604f, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:13 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974147, encodeId=37009e414751, content=好医生, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/2d59f54660e6480cacdbb2833517659d/12b1bb8ee93a41c59a96fcf76a4155c4.jpg, createdBy=b3e85427384, createdName=ms1000001373606354, createdTime=Wed Jun 16 17:56:14 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 北平的俊伟

    没看明白

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=974858, encodeId=168e9e485836, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6e65529012, createdName=ms3000002003870090, createdTime=Sat Jun 19 12:50:03 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974424, encodeId=a71a9e442439, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Thu Jun 17 16:33:15 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974161, encodeId=17a09e41618c, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:42 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974160, encodeId=30fc9e41604f, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:13 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974147, encodeId=37009e414751, content=好医生, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/2d59f54660e6480cacdbb2833517659d/12b1bb8ee93a41c59a96fcf76a4155c4.jpg, createdBy=b3e85427384, createdName=ms1000001373606354, createdTime=Wed Jun 16 17:56:14 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 北平的俊伟

    没看明白

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=974858, encodeId=168e9e485836, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6e65529012, createdName=ms3000002003870090, createdTime=Sat Jun 19 12:50:03 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974424, encodeId=a71a9e442439, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Thu Jun 17 16:33:15 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974161, encodeId=17a09e41618c, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:42 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974160, encodeId=30fc9e41604f, content=没看明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/5627f824aadc4178ba043dac1c087eaa/4a0c7774a1874002b5d5ad1ce7d8a527.jpg, createdBy=7dbe5486508, createdName=北平的俊伟, createdTime=Wed Jun 16 18:46:13 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974147, encodeId=37009e414751, content=好医生, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/2d59f54660e6480cacdbb2833517659d/12b1bb8ee93a41c59a96fcf76a4155c4.jpg, createdBy=b3e85427384, createdName=ms1000001373606354, createdTime=Wed Jun 16 17:56:14 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 ms1000001373606354

    好医生

    0

相关资讯

肿瘤医生专享:2021CSCO诊疗指南,0元领包邮送

👉 本次活动6月7日截止,限领1位/本

ASCO 2021期间马骏团队再发鼻咽癌重磅研究

该试验对局部晚期鼻咽癌患者接受根治性同步放化疗后继续接受卡培他滨节拍辅助化疗的疗效与安全性进行了研究。

ASCO 2021: 放射肿瘤学变革下一个浪潮:放射药物追踪并杀死癌细胞

放射肿瘤学变革,医生报告称,接受了一种直接向肿瘤细胞提供辐射的实验性药物的晚期前列腺癌男性的生存率有所提高。

JGH:高级别浅表非壶腹十二指肠上皮肿瘤的独立预测因子是肿瘤位置和大小

随着内窥镜技术和诊断的不断进展,研究人员已经意识到浅表性非壶腹十二指肠上皮肿瘤 (SNADET) 的发病率一直在增加。

乳腺癌诊疗训练营:开班啦!CSCO BC常务委员聂建云邀您报名

👉 今晚19:30 | Class1《乳腺癌诊断的最新进展》线上开课

2021 ASCO大会日程预告1(6月4日)

开幕式上,ASCO主席洛里-皮尔斯博士(Lori Pierce)将发表主题演讲,并邀请卫生政策方面的专家作为演讲嘉宾。